iGATE RESEARCH has released a report on "Global Prostate Cancer Therapeutics Market to 2020" Global Prostate Cancer Therapeutics Market to 2020 - overview Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some hindrances as well such as the high cost of prostate cancer drugs, low success rate of clinical trials and side effects of treatments among others. Global Prostate Cancer - Key Therapies Analysis: The global market for prostate cancer therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets. Chemotherapy was the second leading therapy for prostate cancer in 2014. However, growth in the targeted therapy is predicted to push chemotherapy back at the third position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing stiff competition from Xtandi drugs which is expected to replace Zytiga as the leading prostate cancer drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at the third and fourth position in 2014. The market share of both Leuplin and Zoladex is likely to plunge during the forecasting period. Lupron is standing at the fifth position. Bayer's targeted therapy drugs Xofigo is also rapidly catching up the market due to advantages such as increase in the overall survival and progression free survival with benign side effects profile. iGATE RESEARCH report titled “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market. The 4 Prostate Cancer Therapy Market covered in the report are as follows: 1. Hormonal Therapy 2. Chemotherapy 3. Immunotherapy 4. Targeted Therapy The above 4 Therapy has been further analyzed in terms of drugs sales and forecast (2011 - 2020): 1. Global Prostate Cancer - Hormonal Therapy Drugs Market • Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists - Zytiga, Gonax • Luteinizing Hormone-Releasing Hormone (LHRH) Analogs - Lupron, Zoladex, Decapeptyl, Eligard, Vantas, Leuplin • Anti-Androgens - Casodex, Xtandi or MDV3100, Xtandi US or MDV3100 2. Global Prostate Cancer - Chemotherapy Drugs Market 1. Taxotere 2. Jevtana 3. Global Prostate Cancer - Immunotherapy Drugs Market 1. Provenge 4. Global Prostate Cancer - Targeted Therapy Drugs Market 1. Xofigo or Alpharadin Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Gl

1. © iGATE Research Page 1 of 13 www.igateresearch.com
Global Prostate Cancer
Therapeutics Market To 2020
iGATE RESEARCH
www.igateresearch.com,
,
Published Date: No. of Pages: 76
May 2015
Copyright © 2015 iGATE Research
By Therapy
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy

2. © iGATE Research Page 2 of 13 www.igateresearch.com
Global Prostate Cancer Therapeutics Market Overview
Prostate Cancer remains a top priority for health systems around the world as incidence level
rises, fueled by growing and aging populations. The main drivers for the prostate cancer
market are the increase in the global aging population, innovation in drugs and developments
in genomics and proteomics. The prostate cancer market faces some hindrances as well such as
the high cost of prostate cancer drugs, low success rate of clinical trials and side effects of
treatments among others.
Global Prostate Cancer - Key Therapies Analysis: The global market for prostate cancer
therapeutics is increasing, driven primarily by the growth in the hormonal therapy markets.
Chemotherapy was the second leading therapy for prostate cancer in 2014. However, growth in
the targeted therapy is predicted to push chemotherapy back at the third position, while
immunotherapy for prostate cancer stands at the last positon in the prostate cancer
therapeutics market.
Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga
is facing stiff competition from Xtandi drugs which is expected to replace Zytiga as the leading
prostate cancer drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at the third
and fourth position in 2014. The market share of both Leuplin and Zoladex is likely to plunge
during the forecasting period. Lupron is standing at the fifth position. Bayer's targeted therapy
drugs Xofigo is also rapidly catching up the market due to advantages such as increase in the
overall survival and progression free survival with benign side effects profile.
iGATE RESEARCH report titled “Global Prostate Cancer Therapeutics Market to 2020” is a
76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer
Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate
cancer market.

3. © iGATE Research Page 3 of 13 www.igateresearch.com
The 4 Prostate Cancer Therapy Market covered in the report are as follows:
1. Hormonal Therapy
2. Chemotherapy
3. Immunotherapy
4. Targeted Therapy
The above 4 Therapy has been further analyzed in terms of drugs sales and forecast (2011
- 2020):
1. Global Prostate Cancer - Hormonal Therapy Drugs Market
 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists - Zytiga, Gonax
 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs - Lupron, Zoladex,
Decapeptyl, Eligard, Vantas, Leuplin
 Anti-Androgens - Casodex, Xtandi or MDV3100, Xtandi US or MDV3100
2. Global Prostate Cancer - Chemotherapy Drugs Market
1. Taxotere
2. Jevtana
3. Global Prostate Cancer - Immunotherapy Drugs Market
1. Provenge
4. Global Prostate Cancer - Targeted Therapy Drugs Market
1. Xofigo or Alpharadin

4. © iGATE Research Page 4 of 13 www.igateresearch.com
Source of Information
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing
distinctive data sets and research material for business reports. This report is built by using
data and information sourced from Proprietary Information Database, Primary and Secondary
Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified
professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small
Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper,
Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on
the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report,
Government Agencies, Libraries And Local Councils and a large number of Paid Databases.

5. © iGATE Research Page 5 of 13 www.igateresearch.com
About Us
iGATE RESEARCH is a global specialist in the field of Market Research, Analytics and
Consulting Services. We serve as a one stop shop for all the market and industry research needs
including Syndicated Research, Customized Research and Analytics Services. iGATE Research is
a gateway of information for various companies, whether it is Building a Strategy, or
Identifying Business Opportunity, Product Expansion, Market/Business Expansion, Competition
Assessment, etc. Combining deep understanding of the industry along with the expertise, we
help our clients in making better Business decisions.
At iGATE, we have a dedicated team of highly qualified and skilled professionals with deep
industry experience and expertise to manage complex report. We aim to offer high quality
Research Solutions to clients across multiple industries including Healthcare, Life Sciences,
Travel and Tourism, Retail, IT, Telecom, Consumer Retailing among others. We strive to
surpass our client’s expectations with every single project report.
iGATE Research team is comprised of Professionals having degree in Engineering, Management
Professionals, Biotech and other experts from relevant fields. The extensive background of our
team enables us to advise clients on a range of business initiatives, product testing, Market
entry, business opportunity, formulate strategy, etc which helps them in making informed
Business decisions.
For more information Visit: www.igateresearch.com
Email: info@igateresearch.com

6. © iGATE Research Page 6 of 13 www.igateresearch.com
Published
By
iiGGAATTEE RREESSEEAARRCCHH
Phone: +91-858-684-0791 (India)
+91-706-527-9335 (India)
Email: info@igateresearch.com
Internet: www.igateresearch.com
© Global Prostate Cancer Therapeutics Market to 2020
iGATE Research Pvt. Ltd., 2015
Edition 1.0
All Rights Reserved.
No part of this Publication may be reproduced or transmitted
in any form or by any means, electronic or mechanical, including
photocopying, recording, or by any information storage
and retrieval system, without permission in
writing from the publisher.

7. © iGATE Research Page 7 of 13 www.igateresearch.com
Table of Contents
1. Executive Summary
2. Global Prostate Cancer Therapeutics Market
3. Global Prostate Cancer Incidence
4. Global Prostate Cancer Therapeutics Market Share & Forecast (2011 - 2020)
4.1 Global Prostate Cancer - Therapy Market Share
4.2 Global Prostate Cancer - Drugs Market Share
5. Global Prostate Cancer Therapy Market & Forecast (2011 - 2020)
5.1 Global Prostate Cancer Hormonal Therapy Market & Forecast
5.2 Global Prostate Cancer Chemotherapy Market & Forecast
5.3 Global Prostate Cancer Immunotherapy Market & Forecast
5.4 Global Prostate Cancer Targeted Therapy Market & Forecast
6. Global Prostate Cancer - Hormonal Therapy Drugs Sales & Forecast to 2020
6.1 Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
6.1.1 Zytiga
6.1.2 Gonax/ Firmagon
6.2 Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
6.2.1 Lupron
6.2.2 Zoladex
6.2.3 Decapeptyl
6.2.4 Eligard
6.2.5 Vantas
6.2.6 Leuplin
6.3 Anti-Androgens
6.3.1 Casodex
6.3.2 Xtandi or MDV3100
6.3.3 Xtandi US or MDV3100
7. Global Prostate Cancer - Chemotherapy Drugs Market
7.1 Taxotere
7.2 Jevtana

8. © iGATE Research Page 8 of 13 www.igateresearch.com
8. Global Prostate Cancer - Immunotherapy Drugs Market
8.1 Provenge
9. Global Prostate Cancer - Targeted Therapy Drugs Market
9.1 Xofigo or Alpharadin
10. Global Prostate Cancer Market - Driving Factors
10.1 Innovative Drugs Driving the Market
10.2 Advancement in Oncology Therapeutic Area
10.3 Developments in Genomics & Proteomics
11. Global Prostate Cancer Market - Challenges
11.1 High Cost of Prostate Cancer Drugs
11.2 Adverse Events of Treatment
11.3 Low Success Rate in Clinical Testing For Oncology Drugs

9. © iGATE Research Page 9 of 13 www.igateresearch.com
List of Figures:
Figure 2-1: Global - Prostate Cancer Therapeutics Market (Million US$), 2010 - 2014
Figure 2-2: Global - Forecast for Prostate Cancer Therapeutics Market (Million US$), 2015 - 2020
Figure 3-1: Global - Prostate Cancer Incidence (Number), 2007 - 2014
Figure 3-2: Global - Forecast for Prostate Cancer Incidence (Number), 2015 - 2020
Figure 5-1: Global Prostate Cancer - Hormonal Therapy Market (Million US$), 2011 - 2014
Figure 5-2: Global Prostate Cancer - Forecast for Hormonal Therapy Market (Million US$), 2015 - 2020
Figure 5-3: Global Prostate Cancer - Chemotherapy Market (Million US$), 2011 - 2014
Figure 5-4: Global Prostate Cancer - Forecast for Chemotherapy Market (Million US$), 2015 - 2020
Figure 5-5: Global Prostate Cancer - Immunotherapy Market (Million US$), 2011 - 2014
Figure 5-6: Global Prostate Cancer - Forecast for Immunotherapy Market (Million US$), 2015 - 2020
Figure 5-7: Global Prostate Cancer - Targeted Therapy Market (Million US$), 2013 - 2014
Figure 5-8: Global Prostate Cancer - Forecast for Targeted Therapy Market (Million US$), 2015 - 2020
Figure 6-1: Global - Zytiga Drugs Sales (Million US$), 2011 - 2014
Figure 6-2: Global - Forecast for Zytiga Drugs Sales (Million US$), 2015 - 2020
Figure 6-3: Global - Gonax/ Firmagon Drugs Sales (Million US$), 2012 - 2014
Figure 6-4: Global - Forecast for Gonax Drugs Sales (Million US$), 2015 - 2020
Figure 6-5: Global - Lupron Drugs Sales (Million US$), 2009 - 2014
Figure 6-6: Global - Forecast for Lupron Drugs Sales (Million US$), 2015 - 2020
Figure 6-7: Global - Zoladex Drugs Sales (Million US$), 2009 - 2014
Figure 6-8: Global - Forecast for Zoladex Drugs Sales (Million US$), 2015 - 2020
Figure 6-9: Global - Decapeptyl Drugs Sales (Million US$), 2009 - 2014
Figure 6-10: Global - Forecast for Decapeptyl Drugs Sales (Million US$), 2015 - 2020
Figure 6-11: Global - Eligard Drugs Sales (Million US$), 2009 - 2014
Figure 6-12: Global - Forecast for Eligard Drugs Sales (Million US$), 2015 - 2020
Figure 6-13: Global - Vantas Drugs Sales (Million US$), 2009 - 2014
Figure 6-14: Global - Forecast for Vantas Drugs Sales (Million US$), 2015 - 2020
Figure 6-15: Global - Leuplin Drugs Sales (Million US$), 2009 - 2014
Figure 6-16: Global - Forecast for Leuplin Drugs Sales (Million US$), 2015 - 2020
Figure 6-17: Global - Casodex Drugs Sales (Million US$), 2009 - 2014
Figure 6-18: Global - Forecast for Casodex Drugs Sales (Million US$), 2015 - 2020
Figure 6-19: Global - Xtandi or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-20: Global - Forecast for Xtandi or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 6-21: Global - Xtandi US or MDV3100 Drugs Sales (Million US$), 2012 - 2014
Figure 6-22: Global - Forecast for Xtandi US or MDV3100 Drugs Sales (Million US$), 2015 - 2020
Figure 7-1: Global - Taxotere Drugs Sales (Million US$), 2011 - 2014

10. © iGATE Research Page 10 of 13 www.igateresearch.com
Figure 7-2: Global - Forecast for Taxotere Drugs Sales (Million US$), 2015 - 2020
Figure 7-3: Global - Jevtana Drugs Sales (Million US$), 2010 - 2014
Figure 7-4: Global - Forecast for Jevtana Drugs Sales (Million US$), 2015 - 2020
Figure 8-1: Global - Provenge Drugs Sales (Million US$), 2011 - 2014
Figure 8-2: Global - Forecast for Provenge Drugs Sales (Million US$), 2015 - 2020
Figure 9-1: Global - Xofigo or Alpharadin Drugs Sales (Million US$), 2013 - 2014
Figure 9-2: Global - Forecast for Xofigo or Alpharadin Drugs Sales (Million US$), 2015 - 2020
Figure 11-1: Therapeutic Categories - Overall Success Rate from Phase 1 through Likelihood of Approval
(Percent), 2004 - 2010

11. © iGATE Research Page 11 of 13 www.igateresearch.com
List of Tables:
Table 4-1: Global - Prostate Cancer Therapy Market Share (Percent), 2011 - 2014
Table 4-2: Global - Forecast for Prostate Cancer Therapy Market Share (Percent), 2015 - 2020
Table 4-3: Global - Prostate Cancer Drugs Market Share (Percent), 2011 - 2014
Table 4-4: Global - Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 - 2020

12. © iGATE Research Page 12 of 13 www.igateresearch.com
Order the Report
Report Title: Global Prostate Cancer Therapeutics Market to 2020
To Order the Report Visit:
http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20Prostate%20Cancer
%20Therapeutics%20Market%20to%202020
Single User License US$ 1,000
Hard-copy Mail Delivery US$ 1,100
CD-ROM Mail Delivery US$ 1,100
Multi User License US$ 1,500
For More Details Visit:
http://www.igateresearch.com/

13. © iGATE Research Page 13 of 13 www.igateresearch.com
Contact US
iGATE RESEARCH PVT. LTD.
Web: www.igateresearch.com
To order the Report:
E-Mail: info@igateresearch.com
Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)
For Report Related Query:
E-Mail: info@igateresearch.com
Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)
Follow US
Facebook: https://www.facebook.com/pages/IGATE-Research/1569079456648005?sk=timeline
Twitter: https://twitter.com/IgateResearch
You Tube: https://www.youtube.com/channel/UCOr7KNn4JfTwk5_kQjj-xrQ
Google+: https://plus.google.com/110560526954506242845/posts
Linkedin:https://www.linkedin.com/profile/view?authType=NAME_SEARCH&locale=en_US&id=
374611590&trk=tyah&trkInfo=tarId%3A1414504898315%2Ctas%3Aigate+research%2Cidx%3A1-1-
1&authToken=YgR7